Bruyère Health is proud to stand among the hospitals, universities, and colleges in the region, highlighting the strength of Ottawa’s health and life science research environment.
Load More
A coalition of Canada's top dementia experts will test the Foresight™ platform by Canadian-based Perceiv Research Inc.
National Art Exhibition Inspires Canadian Artists to Reimagine the End of Life
Health Canada has now approved the use of lecanemab for treating early-stage Alzheimer’s disease.
Bruyère Health is creating a Master Retail Strategy that will help revamp retail and food services across all our sites.
Earlier this year, we launched a pilot project at our Market Site using Friendlier, a reusable food container program.
September 17 marks Rehabilitation Day, a celebration of the critical role of rehabilitation in recovery and quality of life, and the dedicated teams that make this possible.
An international team of researchers has received $1 million to launch one of the largest multinational studies to date examining how cardiovascular health influences the risk of Alzheimer’s disease and related dementias.
New research published in Palliative Care and Social Practice shows that food is much more than fuel for palliative patients.